The S&P 500 is almost unchanged from mid-July, but there have been some major moves under the market's surface.
Another national poll shows Trump trailing Clinton by double digits, as Trump's campaign manager admitted they're behind, report NBC.
TD Ameritrade and Toronto-Dominion Bank on Monday announced plans to acquire Scottrade Financial Services in a deal valued at about $4 billion.
A growing threat of hostile drones is raising concern by military planners and accelerating the development of new weapons systems.
Bob Dylan may have caused the authority behind the Nobel Prize for Literature to have second thoughts.
Goldman Sachs raised its price target on Amazon to $1,050 as it expects cloud revenue to surge.
Forearm Forklift was thriving until cheap knockoffs flooded Amazon, sending sales tumbling and jeopardizing the manufacturer's future.
Wall Street gurus favor dividend-paying stocks for their steady returns. For most Americans, they remain among the surest paths to wealth.
Angela Silverstein made $13,000 in 5 minutes, tax-free, no risk. You may be able to also. How? State-level unclaimed fund offices.
From comic books and coins to wine and racehorses, investors are turning their private passions into profits.
Long-depressed commodity prices are set to finally head higher for two reasons, said Marc Faber, the publisher of the Gloom, Boom & Doom report.
Market jitters don't end when Americans cast ballots. There will be plenty of reasons to stay in protect-your-money mode after the election.
Bankrate found that these 10 metro areas have high rates of homeownership and savings as well as good-paying jobs.
With real safe rates of return exceptionally low and not expected to rise soon, rates should be expected to stay exceptionally low during the forecast horizon, Bullard said.
AT&T Chairman and CEO Randall Stephenson tells CNBC the telecommunications giant's mega-deal to buy Time Warner is a "pure vertical integration."
Some of the names on the move ahead of the open.
GlaxoSmithKline has filed its shingles vaccine Shingrix for U.S. regulatory approval, the drug maker said on Monday.
The government and MetLife are set for a rematch in court on Monday over how federal regulators decide a company is "too big to fail."
A daily look at the morning's key financial stories.